Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Midatech Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Midatech Pharma US Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Midatech Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Midatech Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Midatech Pharma US Inc, Medical Devices Deals, 2012 to YTD 2018 9
Midatech Pharma US Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Midatech Pharma US Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Midatech Pharma US Enters into Co-Promotion Agreement with Bausch Health 11
Midatech Pharma US Enters into Co-Marketing Agreement with R-Pharm US 12
DARA BioSciences Enters into Commercialization Agreement with Onxeo 13
DARA BioSciences Enters into Co-Promotion Agreement with Mission Pharmacal 14
Dara BioSciences Enters Into Agreement With T3D Therapeutics For DB959 15
Licensing Agreements 16
Helsinn Enters Into Licensing Agreement With Dara BioSciences For Gelclair 16
DARA BioSciences Enters Into Licensing Agreement With Innocutis For Bionect 17
DARA BioSciences Enters Into Licensing Agreement With Uman Pharma For Gemcitabine 18
Equity Offering 19
Dara BioSciences Raises USD12.5 Million in Public Offering of Units 19
Dara BioSciences Files Registration Statement For Public Offering Of Units For Up To US$32.5 Million 21
Dara BioSciences Raises USD6 Million in Private Placement Of Shares 22
Dara BioSciences Completes Private Placement Of Shares For US$2.6 Million 23
Dara BioSciences Announces Public Offering Of Common Stock For US$2.7 Million 24
Dara BioSciences Completes Private Placement Of Series B-3 Preferred Stock For US$2.6 Million 25
Dara BioSciences Completes Private Placement Of Series B-4 Preferred Stock For US$0.3 Million 26
DARA BioSciences Completes Public Offering Of Units For US$10 Million 27
DARA BioSciences Completes Private Placement Of Preferred Stock For US$1.7 Million 29
Acquisition 31
Midatech Pharma Acquires Dara BioSciences 31
DARA BioSciences Acquires Oncogenerix 33
Midatech Pharma US Inc – Key Competitors 34
Midatech Pharma US Inc – Key Employees 35
Midatech Pharma US Inc – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 37
Financial Announcements 37
Feb 28, 2018: Pacira Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update 37
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39
Midatech Pharma US Inc, Pharmaceuticals & Healthcare, Key Facts 2
Midatech Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Midatech Pharma US Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Midatech Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Midatech Pharma US Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Midatech Pharma US Inc, Medical Devices Deals, 2012 to YTD 2018 9
Midatech Pharma US Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Midatech Pharma US Enters into Co-Promotion Agreement with Bausch Health 11
Midatech Pharma US Enters into Co-Marketing Agreement with R-Pharm US 12
DARA BioSciences Enters into Commercialization Agreement with Onxeo 13
DARA BioSciences Enters into Co-Promotion Agreement with Mission Pharmacal 14
Dara BioSciences Enters Into Agreement With T3D Therapeutics For DB959 15
Helsinn Enters Into Licensing Agreement With Dara BioSciences For Gelclair 16
DARA BioSciences Enters Into Licensing Agreement With Innocutis For Bionect 17
DARA BioSciences Enters Into Licensing Agreement With Uman Pharma For Gemcitabine 18
Dara BioSciences Raises USD12.5 Million in Public Offering of Units 19
Dara BioSciences Files Registration Statement For Public Offering Of Units For Up To US$32.5 Million 21
Dara BioSciences Raises USD6 Million in Private Placement Of Shares 22
Dara BioSciences Completes Private Placement Of Shares For US$2.6 Million 23
Dara BioSciences Announces Public Offering Of Common Stock For US$2.7 Million 24
Dara BioSciences Completes Private Placement Of Series B-3 Preferred Stock For US$2.6 Million 25
Dara BioSciences Completes Private Placement Of Series B-4 Preferred Stock For US$0.3 Million 26
DARA BioSciences Completes Public Offering Of Units For US$10 Million 27
DARA BioSciences Completes Private Placement Of Preferred Stock For US$1.7 Million 29
Midatech Pharma Acquires Dara BioSciences 31
DARA BioSciences Acquires Oncogenerix 33
Midatech Pharma US Inc, Key Competitors 34
Midatech Pharma US Inc, Key Employees 35
Midatech Pharma US Inc, Subsidiaries 36
List of Figures
Midatech Pharma US Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Midatech Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Midatech Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Midatech Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Midatech Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Midatech Pharma US Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Midatech Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Midatech Pharma US Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Midatech Pharma US Inc, Medical Devices Deals, 2012 to YTD 2018 9